Please enter subscribe form shortcode
Please enter instagram feed shortcode
We design innovative therapeutic and prophylactic platforms using biomaterials and drug delivery principles—leveraging lipid nanoparticles, polymeric carriers, and advanced RNA technologies to develop safer, more effective, and precisely targeted gene-based treatments.
We engineer next-generation immunotherapies and vaccines to tackle gynecologic cancers, pregnancy disorders, and autoimmune diseases—leveraging CAR cell therapies and nucleic acid platforms tailored to the unique immune dynamics of reproduction and infection.
We explore biomaterial interactions with female-specific tissues to design targeted therapies for conditions like pre-eclampsia, preterm birth, and endometriosis—using advanced in vitro, ex vivo, and in vivo models to overcome unique biological barriers in women’s health.
We are hiring! There are multiple open positions at all levels including for post-doctoral fellows, research technicians, graduate students, and undergraduate students. To join us, please contact Kelsey Swingle.